Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 551 - 600 out of 17,332

Document Document Title
WO/2013/129292A1
The purpose of the present invention is to provide a bone cement composition which can have desired biological activity performance and desired radiolucency while enabling the strength of a cured product thereof to be kept. A titanium ox...  
WO/2013/126975A1
The present invention relates to a bioresorbable and bioactive three-dimensional porous material made from bioresorbable polymers that can be combined with bioactive ceramics, producing a three-dimensional structure of interlinked pores ...  
WO/2013/129465A1
Provided is a porous plate for medical applications, which is free of problems inherent in conventional barrier membranes, i.e., thicknesses and proliferation of bacteria, is thin, and has fine through-holes formed therein at a high dens...  
WO/2013/127374A1
The invention relates to a new hyaluronan derivative according to the general formula (I), the method of preparation thereof, a hydrogel based on the new derivative, method of preparation of the hydrogel and the use of the hydrogel in ti...  
WO/2013/130209A1
A collagen-coated tissue based membrane that is smooth on both sides so as to inhibit cell and tissue adhesion. Also disclosed are methods for making a collagen-coated tissue-based membrane.  
WO/2013/129885A1
The present invention relates to a cell culture fluid, and more particularly, to a cell culture fluid which is safe, stable and effective for cell therapy products or the like.  
WO/2013/125924A1
An implant fixture according to the present invention comprises: a fixture body (110) having a guide hole (115) formed into the central axis thereof so that the bottom portion thereof is implanted in the alveolus, wherein a shaft-couplin...  
WO/2013/126635A1
The present disclosure describes an implant for tissue replacement or augmentation including a resorbable non-pyrogenic porous body of irradiated oxidized cellulose, formed from a precursor reactive mixture of irradiated cellulose and an...  
WO/2013/126329A1
The invention features bioscaffolds comprising carbonaceous compositions (e.g., activated charcoal) an extracellular matrix component, and embryonic stem cells or other neuronal stem cells, and in vitro and in vivo methods of using such ...  
WO/2013/124577A1
This orthopaedic implant (1) comprises a polymer substrate (2) with an outer surface (3) intended to be secured to a bone tissue. The outer surface (3) is covered with metal particles (5) comprising titanium. The particles (5) comprise l...  
WO/2013/126294A1
A bone implant primer is provided. A biodegradable hydrogel component is provided. A plurality of biomolecule release depots are dispersed within the biodegradable hydrogel component wherein the plurality of biomolecule release depots co...  
WO/2013/125674A1
[Problem] A main objective of the present invention is to provide a cell preparation useful for treatment of diseases in bone joints and repairing muscles which have been degenerated or damaged. [Solution] The present invention provides ...  
WO/2013/125632A1
Provided are: particularly a composition for enlarging the breast, which comprises a composition for promoting the increase in a subcutaneous tissue, wherein the latter composition enables the recovery of an autologous tissue or the reco...  
WO/2013/124693A1
Provided are methods of manufacturing a superhydrophilicmetal implant material, the method comprising laser processing, with a laser having a wavelength in the visible spectrum, the surface of a metal implant material inan atmosphere com...  
WO/2013/125607A1
The purpose of the present invention is to provide a tissue regeneration substrate ideal for reinforcing fragile tissue and securing the promotion of tissue regeneration in that cell permeability is excellent but tissue adhesion does not...  
WO/2013/126407A1
The present disclosure provides methods to improve the properties of a porous structure formed by a rapid manufacturing technique. Embodiments of the present disclosure increase the bonding between the micro-particles 5 on the surface of...  
WO/2013/126562A1
The present invention involves tissue engineering constructs made from a new composite bone graft material made from biocompatible poly(D,L-lactic-co-glycolic acid) (PLGA) and bioceramic particles exposed on its surface using a gas foami...  
WO/2013/123468A1
A dental prosthetic device (10,1 10) having a base (12,1 12) constructed of an inexpensive remoldable material, such as, for example, ethylene vinyl acetate, to allow for inexpensive and quick fitting and refitting to accommodate changes...  
WO/2013/122981A1
A device for treating a damaged tissue includes an expandable scaffold positionable in a portion of a luminal tissue structure of a mammal; and maintained via stent technology, wherein the scaffold is comprised of electrospun fibers comp...  
WO/2013/122642A3
The disclosed subject matter can provide a nanotube-reinforced polymer composite material comprising a plurality of nanotubes, each nanotube being formed of a plurality of cyclic peptide molecules, disposed within a polymer matrix, such ...  
WO/2013/122492A1
The invention claimed concerns a medical material, the method of its production, as well as use of that medical material manufactured from dibutyrylchitin and chitin regenerated from dibutyrylchitin butyrylchitin esterified to various de...  
WO/2013/123147A1
A graft device including a conduit and a fiber matrix surrounding the conduit for a mammalian patient is disclosed. The graft device further includes a kink resisting element such that the graft device is configured to reduce kinking. Me...  
WO/2013/123275A1
The specification discloses compositions and methods for treating a soft tissue defect of an individual.  
WO/2013/122862A1
A metal matrix has a biocompatible solid lubricant in at least a portion of its surface and the solid lubricant functions to protect the interior of the metal matrix and minimize the friction coefficient and related wear induced damage a...  
WO/2013/123274A1
The specification discloses compositions and methods for treating a soft tissue defect of an individual.  
WO/2013/122584A1
Disclosed are soft, high refractive index, acrylic device materials. The materials contain a multi-arm PEG macromer.  
WO/2013/123018A1
Disclosed is a medical device constructed and arranged for contact with a flow of blood or other bodily fluid of a patient and including an attached binding agent or a roughened surface that binds to pathogenic cells targeted for elimina...  
WO/2013/123049A1
An Inkjet printing method, system, and computer-usable tangible storage device to print cells and biomaterials for three-dimensional cellular scaffolds and engineered skin grafts are disclosed. The process simultaneously deposits living ...  
WO/2013/122765A1
A bone fastener includes a head, an elongated shank defining a longitudinal axis having a proximal end and a distal end. The proximal end is connected to the head and the elongated shank has an inner surface defining a longitudinal cavit...  
WO/2013/119458A1
Provided are porous, biocompatible implant bodies and materials. These materials suitably comprise a population of randomly arranged thermoplastic constituents, with at least some of the constituents being bonded to one another The impla...  
WO/2013/119859A1
According to an aspect of the present invention, surgical films for soft tissue repair are provided. The surgical films comprise at least one sheet of a non-filamentous material within which pores are formed. Further aspects of the inven...  
WO/2013/119772A1
In alternative embodiments, the invention provides products (articles) of manufacture comprising nanostructures such as nanotubes having a surface comprising tantalum. In alternative embodiments, products of manufacture of the invention ...  
WO/2013/118177A1
Provided is a method for manufacturing a diffraction-type multifocal eye lens, said method including a novel diffraction structure design step, with which the optical characteristic of the diffraction-type eye lens can easily be tuned by...  
WO/2013/118125A1
Isolated composites are disclosed comprising collagen fibers isolated from a Sarcophyton sp. coral. An exemplary composite comprises as a first component a bundle of collagen fibers, the collagen fibers being isolated from a Sarcophyton ...  
WO/2013/119058A1
Provided are: antibiotics capable of preventing a bacterial infection that could arise after an orthopedic or dental implant or a scaffold is transplanted, and which simultaneously have bone fusion and bone formation functions; an implan...  
WO/2013/118176A1
Provided is a diffraction-type multifocal eye lens for which halos are reduced, devised using a solving method that is based on the result of an investigation of the mechanism of halos for the purpose of reducing halos. Also provided is ...  
WO/2013/119830A1
According to an aspect of the present invention, surgical scaffolds for soft tissue repair are provided. The surgical scaffolds comprise a sheet of a material within which through-holes are formed. Further aspects of the invention, among...  
WO/2013/116804A3
The present invention provides new classes of phenol compounds, including those derived from tyrosol and analogues, useful as monomers for preparation of biocompatible polymers, and biocompatible polymers prepared from these monomelic ph...  
WO/2013/113249A1
A method for preparing a porous tantalum medical implant material comprises: directly performing selective laser sintering on a raw material, namely, pure tantalum powder with the particle size being less than or equal to 10 μm, so as t...  
WO/2013/113514A1
The invention relates to a cell implant matrix which has a connective porosity of over 80% and which consists predominantly of a mixture of bioresorbable polymers. The matrix has a disk shape, and a surface layer on one face of the disk ...  
WO/2013/113515A1
The invention relates to a porous implant matrix consisting predominantly of a mixture of polymers which degrade at different rates. Nominal resorption times of two of the mixture components, each of which makes up at least 10% of the mi...  
WO/2013/116479A1
Methods of generating an innervated muscle structures are disclosed as well as bioengineered structures for tissue repair or regeneration. The methods can include the steps of obtaining populations of smooth muscle cells and neuronal pro...  
WO/2013/116057A1
The present invention generally relates to silver-containing bioactive antibacterial materials and composites that enhance bone growth while preventing surgical site infection. The present invention also relates to bioactive antibacteria...  
WO/2013/113821A1
The present invention relates to an in vitro or ex vivo method of preparing a cell-free composition, said method comprising or consisting of (a) subjecting cells to stress; and (b) collecting factors produced, preferably secreted by said...  
WO/2013/116224A1
A substantially enriched mammalian multipotent vascular stem cell (MVSC) population is provided, as well as compositions comprising the population. Methods are provided for the isolation, purification, and culture of the MVSCs. The MVSCs...  
WO/2013/114947A1
Provided is a bioimplant that enables long-term prevention of post-surgical biofilm formation. In this bioimplant, a spray coating comprising a calcium phosphate material is formed on at least a portion of a substrate formed from metal, ...  
WO/2013/113517A1
The invention relates to a porous implant matrix consisting predominantly of a mixture of polymers which degrade at different rates. Nominal resorption times of two of the mixture components, each of which makes up at least 10% of the mi...  
WO/2013/113251A1
A method for preparing a porous tantalum medical implant material comprises: mixing a pure tantalum powder with a binding agent to obtain tantalum powder slurry; placing into a steel die a high polymer resin template support which has th...  
WO/2013/116744A1
The present disclosure provides biomaterials and methods for preventing and minimizing progression of cartilage and/or connective tissue damage. Also provided herein are biomaterials and methods for alleviating and/or reducing the risk f...  
WO/2013/114372A1
The present invention is directed to methods of treating an organ or a tissue prior to transplantation thereof into a recipient, comprising ablating the cells composing the blood vessels of said organ or tissue, preferably the cells lini...  

Matches 551 - 600 out of 17,332